3Watanabe Y,Watanabe T,Ando et al. Drug interaction between r adical scavenger,3 - meth- yl - 1 - phenyl - 2 - pyrazolin - 5 - one ( MCI - 186) , and stroke - medicating agents [ J ]. Jpn Pharmacol Ther, 1997,25 ( suppl ) : 1709 -1718.
二级参考文献17
1Jain KK. Neuroprotection in cerebrovascular disease. Expert Opin Investig Drugs, 2000,9:695
2Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi, 2002, 119:301
3Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis, 2003, 15:222
4Tabrizchi R. Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs, 2000,1:347
5Jin YJ, Mima T, Raicu V, et al. Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. Neurosci Res, 2002,43:75
6Tanahashi N, Fukuuchi Y. Treatment of acute ischemic stroke: recent progress. Intern Med, 2002, 41:337
7横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
8Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.
9Kawai H,Nakai H,Misao S,et al.Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].J Pharmacol Exp Ther,1997,281(2)∶921-927.
